Status:
ENROLLING_BY_INVITATION
Starvation in the Treatment of Diabetic Ketoacidosis
Lead Sponsor:
Texas Tech University Health Sciences Center
Conditions:
Diabetes Mellitus
Diabetic Ketoacidosis
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are common, but serious metabolic disorders are often encountered in intensive care. In the intensive care setting, it is common ...
Eligibility Criteria
Inclusion
- Males and females with the diagnosis of diabetic ketoacidosis (defined as blood glucose greater than 250 mg/dL, arterial pH less than 7.3, serum bicarbonate less than 15 mEq/L, and the presence of ketonemia or ketonuria)
- Age between 18-89
- Admission to the Medical Intensive Care Unit
- Able to provide informed consent
Exclusion
- Pregnant and breast-feeding women
- Institutionalized patients or prisoners
- Patients unable to eat by mouth, including intubation, presence of any tube used for enteral feeding (nasogastric tube, orogastric tube, PEG tube, etc.), medical conditions requiring parenteral feeding, and a history of a medical condition that prevented oral intake prior to admission, including achalasia, esophageal cancer, stroke with residual deficits preventing oral intake, amyotrophic lateral sclerosis, or head and neck trauma.
Key Trial Info
Start Date :
December 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06186245
Start Date
December 27 2023
End Date
December 1 2025
Last Update
August 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center
Lubbock, Texas, United States, 79415